Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2009 Apr 24;284(17):11601–11612. doi: 10.1074/jbc.M808026200

H2S Biogenesis by Human Cystathionine γ-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia*,S⃞

Taurai Chiku ‡,1, Dominique Padovani ‡,1, Weidong Zhu §,1, Sangita Singh ‡,§, Victor Vitvitsky , Ruma Banerjee ‡,2
PMCID: PMC2670165  PMID: 19261609

Abstract

Although there is a growing recognition of the significance of hydrogen sulfide (H2S) as a biological signaling molecule involved in vascular and nervous system functions, its biogenesis and regulation are poorly understood. It is widely assumed that desulfhydration of cysteine is the major source of H2S in mammals and is catalyzed by the transsulfuration pathway enzymes, cystathionine β-synthase and cystathionine γ-lyase (CSE). In this study, we demonstrate that the profligacy of human CSE results in a variety of reactions that generate H2S from cysteine and homocysteine. The γ-replacement reaction, which condenses two molecules of homocysteine, yields H2S and a novel biomarker, homolanthionine, which has been reported in urine of homocystinuric patients, whereas a β-replacement reaction, which condenses two molecules of cysteine, generates lanthionine. Kinetic simulations at physiologically relevant concentrations of cysteine and homocysteine, reveal that the α,β-elimination of cysteine accounts for ∼70% of H2S generation. However, the relative importance of homocysteine-derived H2S increases progressively with the grade of hyperhomocysteinemia, and under conditions of severely elevated homocysteine (200 μm), the α,γ-elimination and γ-replacement reactions of homocysteine together are predicted to account for ∼90% of H2S generation by CSE. Excessive H2S production in hyperhomocysteinemia may contribute to the associated cardiovascular pathology.


H2S is the newest member of a growing list of gaseous signaling molecules that modulate physiological functions (1-3). Concentrations of H2S ranging from 50 to 160 μm have been reported in the brain (4), where it appears to function as a neuromodulator by potentiating the activity of the N-methyl-d-aspartate receptor and by altering induction of long term potentiation in the hippocampus, important for memory and learning (5). H2S levels in human plasma are reported to be ∼50 μm, and in vitro studies suggest that it functions as a vasodilator by opening KATP channels in vascular smooth muscle cells (6). A recent in vivo study has demonstrated the efficacy of H2S in attenuating myocardial ischemia-reperfusion injury by protecting mitochondrial function (7). The role of H2S in inflammation is suggested by several studies (8-11); however, the underlying mechanism is unknown. Remarkably, H2S can also induce a state of suspended animation in mice by decreasing the metabolic rate and the core body temperature presumably by inhibiting cytochrome c oxidase in the respiratory chain (12).

Endogenous H2S is presumed to be generated primarily by desulfhydration of cysteine catalyzed by the two pyridoxal phosphate (PLP)3-dependent enzymes in the transsulfuration pathway: cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) (13, 14). In fact, it is widely assumed, based on the reported absences of CSE in the brain (15) and of H2S in the brain of CBS knock-out mice (16), that CBS is the primary source of H2S in this organ, whereas CSE plays the equivalent role in the peripheral vasculature (3). However, recent studies have demonstrated that CSE is both present and active in the brain (17, 18) and that H2S is in fact detected in the brains of transgenic mice lacking CBS (19). The major role of CSE in H2S biogenesis in the peripheral system has been convincingly demonstrated in CSE knock-out mice, which exhibit significantly reduced H2S levels in the serum and lower H2S production rates in aorta and heart (20). The CSE knock-out mice exhibit hypertension and reduced endothelium-dependent vasorelaxation.

CSE belongs to the γ-family of PLP-dependent enzymes and catalyzes α,γ-elimination of cystathionine to give cysteine, α-ketobutyrate, and ammonia (Fig. 1, reaction 1) (21). In principle, a variety of CSE-catalyzed reactions leading to H2S formation can be considered, including cysteine-dependent β-reactions (Fig. 1, reactions 2, 3, and 6) and homocysteine-dependent γ-reactions (reactions 4 and 5). An alternative route to H2S synthesis from cysteine catalyzed by CSE has been proposed to involve β-elimination of cystine, leading to the intermediate formation of thiocysteine (reaction 7), which decomposes to H2S in a nonenzymatic reaction with other thiols (13, 22, 23). However, the significance of cystine as a source of H2S, in the reducing intracellular environment is uncertain.

FIGURE 1.

FIGURE 1.

Cystathionine cleavage and H2S-generating reactions catalyzed by CSE.

In this study, we have elucidated the kinetics of H2S biosynthesis from cysteine and homocysteine catalyzed by recombinant human CSE. The kinetic data have been utilized to simulate the rate of H2S production by CSE at physiologically relevant concentrations of substrates and at three concentrations of homocysteine, to mimic normal, mild, and severe hyperhomocysteinemia, and the simulated data have been validated experimentally. The simulations predict that the relative contribution of homocysteine versus cysteine to H2S biogenesis by CSE increases with the grade of hyperhomocysteinemia. Our studies have led to the identification of two novel sulfur metabolites generated as byproducts of H2S synthesis by CSE, lanthionine and homolanthionine. The latter could serve as a biomarker for H2S production under hyperhomocysteinemic conditions.

EXPERIMENTAL PROCEDURES

Purification of Human CSE

Recombinant human CSE (polymorphic variant S403) was expressed in the Escherichia coli strain BL21(DE3) using an expression plasmid generously provided by Dr. Marcus Wahl (Max Planck Institute, Mantinsried, Germany). The protein was purified as described previously (24) with the following modification. After the Superdex S-200 (Sigma) size exclusion column, the active fractions were pooled, concentrated, and dialyzed against 100 mm Hepes buffer, pH 7.4, before being stored at -80 °C. The concentration of CSE was determined using the Bradford reagent (Bio-Rad) with bovine serum albumin as a standard.

Enzyme Activity Assays

The following assays were employed to assess CSE activity. In all assays, the concentration of the variable substrate ranged from 0.2 × Km1 to 30 × Km1. One unit of activity is defined as the amount of enzyme needed to form 1 μmol of product min-1.

Detection of Cysteine—The DTNB assay was used to measure cysteine produced by CSE from cystathionine, as described previously (25). Briefly, 970 μl of Hepes buffer (100 mm, pH 7.4) containing various amounts of a diasteromeric mix of cystathionine was mixed with 10 μl of 0.1 m DTNB (in ethanol) and incubated at 37 °C for 3 min. PLP was omitted from the reaction mixture, since its addition consistently leads to a slight inhibition of the enzymatic activity. Enzyme (20 μl of 1 mg/ml protein) was added to initiate the reaction, and an increase in absorption at 412 nm due to formation of the nitrobenzene thiolate anion was monitored for 1 min in a Cary100 UV-visible spectrophotometer thermostatted at 37 °C. Control experiments lacking CSE or substrate yielded the background rates for the reaction of DTNB with the free thiols of CSE or the impurities contained in cystathionine (∼90% purity) and were subtracted from the enzyme assay data. A molar extinction coefficient of 13,600 m-1 cm-1 was used to estimate the concentration of cysteine generated.

Detection of H2S—H2S generation was measured in one of two ways. For in-gel assays, H2S production was assayed by reaction with lead acetate using a modification of a previously described method (26, 27). Purified CSE (40 μg/lane) was loaded into wells of a native 4-15% gradient Tris-glycine gel (Bio-Rad). Immediately after gel electrophoresis (at 4 °C), the gel was cut between the lanes, and the strips were soaked for 6 h at room temperature in 40 ml of the reaction mixture (100 mm Hepes buffer (pH 7.4), 0.4 mm lead acetate, and substrates: reaction 1 (30 mm l-homocysteine), reaction 2 (10 mm l-cysteine, 30 mm l-homocysteine), or reaction 3 (10 mm l-cysteine)). Bands producing H2S developed a dark brown color that was analyzed using the Gel Doc 2000 gel documentation system (Bio-Rad).

Production of H2S by CSE from different substrates was measured in a spectrophotometric assay in which the reaction of H2S with lead acetate to form lead sulfide was monitored continuously by the increase in absorption at 390 nm. After the reaction mixture (980 μl) containing 100 mm Hepes buffer (pH 7.4), 0.4 mm lead acetate, and varying concentrations of substrate (homocysteine, cysteine, or both) was preincubated at 37 °C for 4 min, 20 μg of CSE was added to the assay mixture to initiate the reaction, which was monitored at 37 °C for 3 min. Lead acetate (0.4 mm) did not inhibit CSE, as determined in the DTNB assay described above. The molar extinction coefficient for lead sulfide under these conditions was determined to be 5,500 m-1 cm-1 using NaHS as a standard.

Detection of α-Ketoacid Products—Determination of α-ketoacids generated in the CSE assay was performed as described (28, 29). Briefly, 1 ml of the assay mixture containing 100 mm Hepes buffer (pH 7.4) and varying concentrations of homocysteine or cysteine was preincubated for 5 min at 37 °C, and the reaction was initiated by adding 20-50 μg of CSE. At the desired time points, 200-μl aliquots of the reaction mixture were quenched by adding 200 μl of 10% trichloroacetic acid. The precipitated proteins were removed by centrifugation at 14,000 × g for 10 min, and 200 μl of the supernatant was mixed with 500 μl of 0.5 m sodium acetate buffer, pH 5.0, and 200 μl of 0.1% 3-methyl-2-benzothiazolinone hydrazone hydrochloride and then incubated at 50 °C for at least 30 min. The control experiment lacking substrate was performed in parallel. After the mixture cooled down to room temperature, the absorbance at 316 nm was read. The concentration of α-ketobutyrate in the reaction mixture was calculated using a standard curve generated with known concentrations of α-ketobutyrate. The concentration of pyruvate in the reaction mixture was calculated similarly by measuring the absorbance at 324 nm and using the appropriate standard curve.

HPLC Analysis of Cystathionine—The HPLC method was used to estimate the rate of cystathionine formation (reaction 6) at 10 mm cysteine and varying concentrations of homocysteine. The concentration of cystathionine was determined following o-phthaldialdehyde derivatization, essentially as described previously (30, 31). Briefly, the enzymatic reaction was stopped by the addition of an equal volume of 10% trichloroacetic acid, and the precipitated protein was removed by centrifugation. The supernatant was neutralized to pH 7-8 with a small amount of saturated K2CO3 and diluted 1:4 with borate buffer (0.2 m, pH 9.6). A 50-μl aliquot of each sample was removed and derivatized with 25 μl of o-phthaldialdehyde solution (15 mm o-phthaldialdehyde, 30 mm 2-mercaptoethanol, and 10% methanol in 0.2 m sodium borate buffer, pH 9.6) in an autosampler (Agilent 1100 series) for 1 min at 10 °C. A 10-μl aliquot of the derivatized sample was then injected into the HPLC column (ZORBAX Eclipse XDB-C18 (5-μm) analytical column 4.6 × 150 mm) and eluted at a flow rate of 1 ml/min with buffers A (80% 0.1 m sodium acetate and 20% methanol, pH 4.75) and B (20% 0.1 m sodium acetate and 80% methanol, pH 4.75). The following increasing gradient of buffer B was used for elution: 0-10 min, 30-60%; 10-15 min, 60-100%; 15-20 min, 100%; 20-22 min, 100-30%; 22-30 min, 30%, with a corresponding decrease in the percentage of buffer A. The detector was set at 340-nm excitation and 450-nm emission wave-lengths. Under these conditions, cystathionine eluted with a retention time of 14.06 min. The concentration of cystathionine was determined using calibration coefficients obtained with the standard. The same HPLC method was used to analyze whether serine and homoserine were produced by the CSE-catalyzed α,β-elimination (reaction 2) and α,γ-elimination (reaction 4) reactions, respectively. The retention times for these compounds were 4.17 min (serine) and 5.26 min for homoserine.

H2S Production at Physiologically Relevant Concentrations of Substrate—H2S formation was detected using the lead acetate assay described above with the following exception. The reaction mixture (1-ml final volume) contained 100 mm Hepes buffer (pH 7.4), 0.4 mm lead acetate, 5 μm cystathionine, 100 μm cysteine, and either 10, 40, or 200 μm homocysteine. Following incubation at 37 °C for 4 min, the reaction was initiated by the addition of 100 μg of CSE (corresponding to 2.2 μm active sites), and the reaction was monitored at 390 nm for 3 min. The higher concentration of protein was necessary for monitoring the slow reaction rates at these low substrate concentrations. We note that the total substrate concentration for H2S generation (i.e. cysteine and homocysteine) varied from 50- to 140-fold excess over the concentration of active sites, and ∼2-10 turnovers were completed during the 3-min time course of the assay.

Mass Spectrometric (MS) Analysis of Reaction Products

For the qualitative analysis of other products in H2S generation reactions, a Q TRAP™ mass spectrometer (Applied Biosystems) equipped with a Turbo ion spray source operated in the positive ion mode was employed. Data acquisition was conducted using Analysis software (Applied Biosystems) with a built-in information-dependent acquisition scan function. The supernatant from the assay mixture obtained after protein precipitation by trichloroacetic acid was injected into the mass spectrometer. Control reaction mixtures from which CSE was omitted were run separately.

Analysis of Kinetic Data

Cystathionine, the substrate for CSE, is a condensation product of two amino acids, serine and homocysteine. The active site pocket therefore has binding determinants for two amino acids. In the H2S-generating reactions catalyzed by CSE (reactions 2-6), either one (reaction 2 and 4) or both (reactions 3, 5, and 6) amino acid binding pockets are occupied. We refer to the kinetic parameters associated with the single substrate reaction (i.e. ignoring H2O) as Km1 and Vmax1. The parameters Km2 and Vmax2 then refer to substrate binding at the second site and the reaction velocity of the bimolecular reaction involving two amino acids, respectively.

Cysteine Production from Cystathionine—The Km and Vmax values for reaction 1 were determined directly from Michaelis-Menten kinetic analysis using the DTNB assay described above and Equation 1.

graphic file with name M1.gif (Eq.1)

We note that commercially available cystathionine is a mixture of diastereomers of which only one, the l,l-isomer, is expected to serve as substrate for CSE. Hence, the substrate concentration was divided by a factor of 4 to obtain the value for Km that is reported.

Pyruvate or α-Ketobutyrate Generation—The Km and Vmax values for CSE-catalyzed pyruvate (reaction 2) or α-ketobutyrate (reaction 4) production from cysteine or homocysteine, respectively, were determined using the α-ketoacid assay described above and Equations 2 and 3.

graphic file with name Image-02.jpg

To account for the observed substrate inhibition, an inhibition constant (i.e. the Ki term) was included in Equations 2 and 3.

H2S Production from Cysteine or Homocysteine—In principle, the reactions for H2S production by CSE can follow either a binary (ping-pong) or ternary or sequential (random or ordered) mechanism. Hence, the experimental data for H2S production from cysteine (i.e. reactions 2 + 3) or from homocysteine (i.e. reactions 4 + 5) monitored by the continuous lead acetate assay described above were fitted using Equations 4-6.

graphic file with name Image-03.jpg

Binding of the second mole of cysteine or homocysteine in reactions 3 and 5, respectively, will affect the Vmax1 values for H2S formation in the unimolecular reactions 2 and 4. To account for this, an inhibition term where Ki = Km2 was introduced as shown in Equations 4-6.

Equations 4-6 describe a random sequential, ordered sequential, and ping-pong mechanism, respectively. A Hill coefficient was included in these equations to account for cooperativity of binding for the second substrate, which was indicated by the kinetic data and our fitting attempts. Equations 4-6, as written, describe vH2S from cysteine (i.e. reactions 2 + 3) for the alternative mechanisms.

For analysis of vH S from homocysteine (i.e. reactions 4 + 5), Equations 4-6 were 2also employed, making the corresponding substitutions (i.e. [Cys] for [HCys], etc.). Unlike cysteine, the dependence of the reaction velocity for H2S generation on homocysteine concentration did not show two well separated phases. Hence, the values for Km1(Hcys), Vmax1, and Ki for α-ketobutyrate generation (obtained from Equation 3) were used as input parameters in Equations 4-6. The quality of fits obtained for the ordered sequential mechanism was significantly worse than for the other two mechanisms (Tables S1 and S2). In contrast, the quality of fits for the ping-pong versus the random sequential mechanism was indistinguishable.

Cystathionine Production from Cysteine Plus Homocysteine—The Km and Vmax values for reaction 6 were determined using the HPLC assay for cystathionine formation, as described above, and Equation 7.

graphic file with name Image-04.jpg

In principle, reaction 6 can follow either a binary or ternary mechanism with either cysteine or homocysteine binding first. However, a reasonable fit was only obtained for the ping-pong mechanism where cysteine binds first (Table S3). Equation 7 describes a ping-pong mechanism, in which competitive inhibition terms for the binding of the first and second substrates were included, since the simultaneous presence of both substrates leads to competition at each binding site by the other substrate (Ki(Hcys) = Km1(HCys) and Ki(Cys) = Km2(Cys)).

H2S Production from Cysteine and Homocysteine—Next, the goodness of the kinetic parameters obtained for reactions 2-6 was assessed by fitting the experimental data for H2S formation obtained in the presence of 10 mm cysteine and varying concentrations of homocysteine. In this set of experiments, the observed rate of H2S production represents the sum of reactions 2-6, as described by Equation 8.

graphic file with name M2.gif (Eq.8)

The values of v2-v6 corresponding to the reaction velocities for 2-6 were computed using Equations 9-13 for the ping-pong mechanism,

graphic file with name Image-05.jpg

graphic file with name Image-06.jpg

where n, h, and k represent the Hill coefficient for the binding of the second substrate in reactions 3, 5, and 6, respectively, and the kinetic parameters were obtained as described above. A term for competitive inhibition (Km(1 + [I]/Ki)) was introduced in Equations 9-13, since the simultaneous presence of both substrates leads to competition for each binding site by the other substrate.

Determination of the Rates of H2S Production at Physiological Substrate Concentrations—The contributions of the various CSE-catalyzed reactions to total H2S production were computed at normal, medium, and high homocysteine concentrations (10, 40, and 200 μm, respectively), using Equations 9-13. The following steady concentrations of substrates were used: [homocysteine] = 10, 40, or 200 μm; [cysteine] = 100 μm; [cystathionine] = 5 μm. The Ki for cystathionine was ignored, since the concentration of cystathionine used to simulate physiological conditions is low (5 μm), whereas the Ki for cystathionine for H2S production is relatively high (0.78 ± 0.1 mm). For instance, the inclusion of the Ki term for cystathionine affected the value for v2 by <2%. The values for v1 corresponding to reaction 1, at varying homocysteine concentrations, were computed using Equation 14,

graphic file with name Image-07.jpg

where cysteine and homocysteine act as competitive inhibitors for binding of cystathionine. Ki(Cys) and Ki(HCys) were assumed to be equal to Km1(Cys) and Km1(HCys) respectively.

The resulting reaction rates (v1-v6) for reactions 1-6 were then used to calculate the turnover numbers (i.e. v/[E]) for each reaction at the substrate concentrations described above and are expressed per mole of CSE active site.

RESULTS

Purification and Biophysical Characterization of CSE—Purification of recombinant human CSE was accomplished in three chromatographic steps, and the purified protein was judged to be ∼95% pure by gel electrophoresis (Fig. 2, inset). The typical yield was ∼20 mg of pure protein/liter of culture. The specific activity of as-purified CSE is 3.1 ± 0.1 units/mg in the DTNB assay with cystathionine as substrate and is similar to the value published previously (2.5 units/mg) (25). As expected, the absorption spectrum of purified CSE is typical of a PLP-dependent enzyme with a maximum at 428 nm and a 280:428 nm ratio of ∼1:6 (Fig. 2).

FIGURE 2.

FIGURE 2.

Purification and characterization of recombinant human CSE. The UV-visible absorption spectrum of CSE (1.7 mg/ml in 70 mm Tris-HCl buffer, pH 8.1, containing 2 mm EDTA and 150 mm NaCl) exhibits a maximum at 428 nm due to PLP. Inset, purity of CSE (20 μg) detected on a 12% SDS-polyacrylamide gel by Coomassie Blue staining. The sizes of the molecular weight standards (M) are shown.

H2S Production by Human CSE—The ability of human CSE to generate H2S was first assessed by an in-gel activity assay. For this experiment, native gel strips containing equal amounts of purified CSE were exposed to the following conditions (30 mm homocysteine, 30 mm homocysteine plus 10 mm l-cysteine, or 10 mm l-cysteine). H2S generation was revealed by the appearance of a dark lead sulfide-containing band on the gel. As shown in Fig. 3 (inset), the most intense bands were seen in the presence of homocysteine (lane a). When both homocysteine and cysteine were present in the reaction mixture, lower H2S production was observed (lane b), whereas cysteine alone supported the lowest level of H2S generation (lane c). These results indicate that at saturating concentrations, homocysteine rather than cysteine is the more effective substrate for H2S generation by CSE. We note that CSE migrates as three bands on the native gel, indicating that although the major population is a tetramer (fastest migrating band), a minor proportion exists as higher order oligomers.

FIGURE 3.

FIGURE 3.

H2S generation by CSE. The reaction of H2S with lead acetate to form lead sulfide was monitored by the increase in absorbance at 390 nm under quasi-steady-state conditions, as described under “Experimental Procedures,” using as substrates 30 mm homocysteine (a), 30 mm homocysteine plus 10 mm cysteine (b), and 10 mm cysteine (c). Inset, in-gel activity staining of CSE. 40 μg of CSE was loaded in each lane and separated on a 4-15% native gradient gel, and H2S-producing activity was detected as described under “Experimental Procedures.” Although the major band corresponds to the native tetrameric form of CSE, a small proportion appear as high order oligomers. The molecular weight markers (M) were stained with Coomassie Blue.

The kinetics of H2S generation by CSE were further characterized using a continuous spectrophotometric assay. The specific activities under Vmax conditions for H2S formation are 6.6 ± 0.5 units/mg from homocysteine and 1.2 ± 0.3 units/mg from cysteine (Table 1). As also seen in Fig. 3, the rate of H2S formation from homocysteine is higher than from cysteine or from homocysteine plus cysteine. The decrease in the initial velocity of H2S formation when both substrates are present in comparison with the rate observed with homocysteine alone results from the occupancy of a portion of the enzyme active sites by the slower substrate, cysteine. This has the net effect of decreased total H2S flux generation. Conversely, the apparent activation of H2S production when both substrates are present in comparison with cysteine alone results from the fraction of the enzyme that is catalyzing homocysteine-dependent H2S production, which occurs at a faster rate than from cysteine. Propargylglycine, a suicide inhibitor of CSE (32), completely blocked H2S formation (not shown). Unlike rat CSE that reportedly uses cystine (Fig. 1, reaction 7) rather than cysteine to generate H2S (23), H2S formation from cystine was not observed with human CSE (data not shown).

TABLE 1.

Kinetic parameters for reactions catalyzed by CSE

All values are the average of at least three independent experiments ± S.D.

Reaction Number Vmax Km Ki n kcat kcat/Km
unitsa/mg mm mm s−1 mm−1 s−1
γ-Elimination of cystathionine 1 3.1 ± 0.1 0.28 ± 0.03 2.3 8.2
Pyruvate generation 2 0.42 ± 0.07 3.7 ± 1.1 32.0 ± 9.5 0.31 0.08
H2S generation from Cys 2 0.6 ± 0.1 1.7 ± 0.7 33 ± 8 0.47 0.27
3 1.2 ± 0.3 33 ± 8b 3.0 ± 1.0 0.85 0.026c
α-Ketobutyrate generation 4 1.2 ± 0.3 2.7 ± 1.4 14.5 ± 6.8 0.92 0.35
H2S generation from HCys 4 1.2 ± 0.3 2.7 ± 0.85 14.5 ± 6.8 0.92 0.35
5 6.6 ± 0.47 5.9 ± 1.2b 1.8 ± 0.6 4.9 0.83c
Cystathionine generation 6 0.20 ± 0.03 12.0 ± 5.4d 1.6 ± 0.7 0.15 0.012d
a

A unit of activity is defined as 1 μmol of product generated min−1 at 37°C.

b

The Km value corresponds to Km2 (i.e. for binding of substrate to site 2).

c

The kcat/Km value is reported relative to Km2.

d

The value represents Km(HCys), and the kcat/Km value is reported relative to Km(HCys).

Product Analysis of H2S-producing Reactions—To distinguish between the multiple routes for H2S generation by CSE (Fig. 1, reactions 2-6), reaction products were analyzed by mass spectrometry, HPLC, and UV-visible absorption spectroscopy for detection of the keto acids, pyruvate and α-ketobutyrate (28). In the presence of cysteine, pyruvate and a novel metabolite, lanthionine (m/z = 209; Fig. 4), were observed, consistent with an α,β-elimination reaction (reaction 2) and a β-replacement reaction (reaction 3). In the presence of homocysteine and cysteine, cystathionine (m/z = 223; Fig. 4) was detected, consistent with a γ-replacement reaction (reaction 6). In the presence of homocysteine alone, not only was α-ketobutyrate detected, consistent with an α,γ-elimination (reaction 4), but a new metabolite, homolanthionine (m/z = 237; Fig. 4), was seen, indicating the γ-replacement of one molecule of homocysteine by another (reaction 5). Serine and homoserine, the products of β- and γ-elimination reactions, respectively (reactions 2 and 4), were not detected by HPLC, but their down-stream products, pyruvate and α-ketobutyrate, respectively, were observed. Lanthionine and homolanthionine are structural homologs of cystathionine that differ by the absence or presence of an extra methylene group, respectively. The identity of homolanthionine was confirmed by MS/MS analysis in which two daughter ion peaks were assigned with m/z = 102 (corresponding to HOOCCH(NH2)CH2CH2)) and 134 (corresponding to SCH2CH2CH(NH2)COOH) that were 14 atomic mass units heavier than the corresponding peaks seen in the MS/MS spectrum of cystathionine (not shown). The identity of lanthionine was confirmed by MS/MS analysis, which was identical to that of a commercial sample of lanthionine in which two daughter ion peaks were assigned with m/z = 120 (corresponding to SCH2CH(NH2)COOH) and m/z = 192 (corresponding to loss of NH3 from lanthionine) (not shown). These data establish that homolanthionine and lanthionine produced by CSE are derived from homocysteine and cysteine, respectively.

FIGURE 4.

FIGURE 4.

Product analysis by MS of the CSE-catalyzed reactions in the presence of homocysteine plus cysteine (A), homocysteine alone (B), or cysteine alone (C). Parent ions with m/z values of 122 (cysteine), 136 (homocysteine), 209 (lanthionine), 223 (cystathionine), 237 (homolanthionine), 241 (cystine), and 269 (homocystine) are seen.

Effect of Nitric Oxide (NO) on H2S-producing Activity of CSE—Previously, it has been reported that the NO donor, sodium nitroprusside, increases the endogenous levels of H2S in vascular tissues (6). The mechanism of this increase was proposed to involve either an NO-induced increase in CSE activity or NO-dependent up-regulation of CSE expression (6). However, we observed no effect of sodium nitroprusside on H2S production by CSE (data not shown), indicating that the effect of NO is not at the level of CSE activity.

Kinetics of H2S Generation by CSE—Product analyses provided direct evidence for five of the six possible CSE-dependent H2S-generating reactions described in Fig. 1(i.e. reactions 2-6). The kinetics of pyruvate (reaction 2) and α-ketobutyrate (reaction 4) formation from cysteine and homocysteine, respectively, and the kinetics of H2S formation from the same substrates (i.e. reactions 2 + 3 or reactions 4 + 5) are shown in Fig. 5. The kinetic data were fitted to alternative mechanisms (i.e. binary versus ternary), and the data are presented in Tables S1 and S2. The values of the kinetic parameters obtained from fits to the ping-pong mechanism allowed deconvolution of the Km and Vmax values associated with each of the four reactions (Table 1). The dependence of the rate of H2S formation on cysteine concentration is markedly biphasic (Fig. 5B). CSE exhibits a considerably higher affinity for cysteine binding to site 1 (3.7 ± 1.1 mm) than to site 2 (33 ± 8 mm), and cooperativity for binding of the second mole of cysteine was seen (n = 3 ± 1).

FIGURE 5.

FIGURE 5.

Kinetics of α-ketoacids and H2S generation by CSE in the presence of cysteine or homocysteine. Shown are the kinetics of pyruvate (A) (reaction 2) or α-ketobutyrate (C) (reaction 4) generation from cysteine or homocysteine, respectively. Also shown are kinetics of H2S generation from cysteine (B) (reactions 2 + 3) or from homocysteine (D) (reactions 4 + 5). The contributions of the component reactions (v2 and v3 in B and v4 and v5 in D) to the net rate of H2S generation are shown. Each data point represents the mean ± S.D. of at least three independent experiments. The data were analyzed as described under “Experimental Procedures,” and the kinetic parameters obtained from these plots are shown in Table 1.

Deconvolution of the two phases contributing to the rate of H2S formation from homocysteine (Fig. 5D) reveals that the Km for site 1 is 2-fold lower than for site 2 (2.7 ± 1.4 and 5.9 ± 1.2 mm, respectively). The kinetics of reaction 6 (i.e. the condensation of homocysteine and cysteine) were monitored by the rate of cystathionine formation. The kinetic data could only be fit with a ping-pong mechanism in which cysteine is the first substrate to bind (Table S3). The relative catalytic efficiencies (i.e. kcat/Km) for the five H2S-generating reactions follow the order 5 > 4 > 2 > 3 > 6 (Table 1).

The kinetic parameters obtained for reactions 2-6 were then employed to simulate the kinetics of H2S formation in the presence of cysteine and homocysteine (Fig. 6A). The excellent correspondence between the simulated and experimental data supports the validity of the kinetic parameters reported in Table 1.

FIGURE 6.

FIGURE 6.

The relative contributions of reactions 2-6 to H2S production at varying homocysteine concentrations. A, the rate of H2S production (○) observed in the presence of 10 mm cysteine and varying concentration of homocysteine in 0.1 m Hepes buffer, pH 7.4, at 37 °C. Each data point represents the mean ± S.D. of three independent experiments. The relative contributions of the individual reactions (v2-v6) to the net rate of H2S production (solid line) were simulated using the kinetic parameters reported in Table 1 and as described under “Experimental Procedures.” B, the contributions of the individual reactions (2-6) to H2S production by CSE were calculated at normal (10 μm), moderate (40 μm), and high (200 μm) concentrations of homocysteine and physiological concentrations of cystathionine and cysteine (5 and 100 μm, respectively) (Table 2). The reaction numbers are indicated above the bar graphs on the left. C, the relative proportions of CSE-derived H2S from cysteine versus homocysteine at three concentrations of homocysteine and physiological concentrations of cysteine and cystathionine (Table 3).

Relative Contributions of the CSE-catalyzed Reactions to H2S Generation—Since the cleavage of cystathionine (reaction 1) represents the primary function of CSE in the transsulfuration pathway, it is pertinent to compare the catalytic efficiency of this reaction with those of the side reactions leading to H2S generation (Table 1). Under Vmax conditions, the most efficient H2S-generating reaction (i.e. γ-replacement of homocysteine (reaction 5)) exhibits a kcat/Km value that is ∼10-fold lower than that for the α,γ-elimination of cystathionine. Furthermore, the Km for cystathionine (0.28 ± 0.03 mm) is significantly lower than for homocysteine.

In the cell, the substrate concentrations are low compared with their Km values (i.e. [S] ≪ Km). Under these conditions, most of the enzyme active sites are unoccupied, and the partitioning of CSE into the various H2S-generating reactions is governed by the rate of each reaction (i.e. v = Vmax[S]/Km). This is distinct from the situation under in vitro steady-state assays conducted at high concentrations of substrate, where the kcat/Km ratio determines the enzyme specificity for competing substrates. Thus, in the cell, substrate availability will play a crucial role in determining the partitioning of CSE between competing reaction paths, and regulatory mechanisms are likely to exist that lead to enhanced or diminished production of H2S and to the diversion of CSE from its role in the transsulfuration pathway.

Using the kinetic parameters described in Table 1, we simulated the relative contributions of each of the reactions to total H2S production at three concentrations of homocysteine, representing normal (10 μm) versus moderate (40 μm) and severe (200 μm) hyperhomocysteinemia (Tables 2 and 3 and Fig. 6, B and C). According to our simulations, under normal conditions, α,β-elimination of cysteine (reaction 2) is predicted to be the major source of CSE-derived H2S, accounting for ∼70% of the total (Table 3 and Fig. 6, B and C). The α,γ-elimination of homocysteine (reaction 4) is the next significant contributor (∼29%), whereas the β- and γ-replacement reactions (reactions 3, 5, and 6) are of negligible importance. The balance between the reaction shifts, however, with increasing concentrations of homocysteine such that the α,γ-elimination of homocysteine (reaction 4) becomes a significant source of H2S at moderate and the principal source of H2S at severely elevated homocysteine concentrations (Fig. 6, B and C). The condensation reaction between 2 mol of cysteine (reaction 3) is a minor contributor to the net H2S pool. Since the rate of reaction 5 has a square dependence on the concentration of homocysteine, it exhibits the greatest sensitivity to increasing homocysteine concentrations, changing ∼230-fold between 10 and 200 μm homocysteine (Table 3). Homolanthionine production could therefore be a useful biomarker for H2S production at high homocysteine concentrations. Generation of H2Sbythe γ-replacement of homocysteine (reaction 5) accounts for ∼13%) of total H2S generation by CSE under conditions of severe hyperhomocysteinemia. Cystathionine formation (reaction 6) is also predicted to rise with increasing homocysteine (Table 3), but it is unlikely to build up, since it is an efficient substrate for CSE. Under conditions of cystinuria, lanthionine production via reaction 3 would be expected to increase.

TABLE 2.

Kinetic parameters for the CSE-catalyzed reactions at varying homocysteine concentrations

Substrate Reaction numbera Vmaxb Km1 (Km2)c v/[E], 10 μm HCysd v/[E], 40 μm HCys Changee v/[E], 200 μm HCys Change
units/mg mm s−1 sec−1 -fold s−1 -fold
Cystathionine 1 3.10 0.28 0.03916 0.03874 0.99 0.03666 0.94
Cys 2 0.42 3.7 8.1 × 10−3 8.03 × 10−3 0.99 7.5 × 10−3 0.92
Cys + Cys 3 1.2 3.7 (33) 2.85 × 10−8 2.83 × 10−8 0.99 2.76 × 10−8 0.97
HCys 4 1.2 2.7 3.35 × 10−3 0.01319 3.9 0.06069 18.1
HCys + HCys 5 6.6 2.7 (5.9) 4.16 × 10−5 5.24 × 10−4 12.6 9.74 × 10−3 234
Cys + HCys 6 0.20 3.7 (12.0) 1.75 × 10−6 1.60 × 10−5 9.1 2.0 × 10−4 114
a

The reaction numbers correspond to those shown in Fig. 1.

b

One unit corresponds to 1 μmol of product formed min−1. The Km and Vmax values were determined as described under “Experimental Procedures” and reported in Table 1.

c

In reactions involving two substrates, the order of the Km values reflects the substrate order in the first column.

d

The values for the turnover numbers at varying concentrations of homocysteine and physiological concentrations of cystathionine (5 μm) and cysteine (100 μm) were obtained as described under “Experimental Procedures” considering a ping-pong mechanism for the bimolecular reaction and the Hill coefficients (n) reported in Table 1.

e

-Fold change refers to the change in v/[E] with respect to normal conditions (i.e. 10 μm homocysteine, which is assigned a value of 1 for each reaction).

TABLE 3.

The relative contributions of H2S-generating reactions at varying concentrations of homocysteine as predicted from kinetic data analyses

The reaction numbers correspond to those shown in Fig. 1. Values shown are the percentage contribution of each reaction to net H2S production at each concentration of homocysteine in the presence of 5 μm cystathionine and 100 μm cysteine.

Substrate Reaction number 10 μm HCys 40 μm HCys 200 μm HCys
% % %
Cys 2 70.5 36.9 9.6
Cys + Cys 3 2.5 × 10−4 1.3 × 10−4 3.5 × 10−5
HCys 4 29.1 60.6 77.7
HCys + HCys 5 0.36 2.4 12.5
HCys + Cys 6 0.015 0.07 0.26

Comparison of Experimental versus Simulated Kinetic Data at Physiological Concentrations of Substrates—To test the validity of the simulations described above, the kinetics of the CSE-catalyzed production of H2S at substrate concentrations chosen to mimic their physiological levels were determined. At low homocysteine concentrations (10 μm), 70% of H2Sispredicted to result from the α,β-elimination of cysteine (v/[E] = 0.0081 s-1) and 29% from the α,γ-elimination of homocysteine (v/[E] = 0.00335 s-1) (Table 2). The experimentally observed turnover number for H2S formation under these conditions was 0.012 ± 0.001 s-1 and similar to the calculated value of 0.0115 s-1. As the concentration of homocysteine increases, the net rate of H2S production is expected to increase. In addition, the proportion of H2S that is derived from homocysteine increases from 29 to 63 to 90% as homocysteine increases from 10 to 40 to 200 μm, respectively (Table 3). In contrast, the rate of H2S production from cysteine is virtually unchanged, whereas the proportion of cysteine-derived H2S decreases from 70 to 37 to 10%. The value of v/[E] for H2S generation is predicted to increase to 0.0217 and 0.0781 s-1 at 40 and 200 μm homocysteine, respectively. The experimentally observed v/[E] values for H2S formation under these conditions were found to be 0.015 ± 0.007 s-1 (40 μm homocysteine) and 0.06 ± 0.001 s-1 (200 μm homocysteine). The excellent correspondence between the experimentally measured and predicted turnover numbers for H2S production support the validity of the simulations reported here.

DISCUSSION

The nonenzymatic liberation of H2S from organic polysulfides in garlic bulbs has been reported recently and provides a mechanistic explanation for the vasoactivity of dietary garlic (33). However, despite the growing interest in H2S biology and the therapeutic potential of H2S-releasing compounds (2), surprisingly little is known about the enzymatic production of this gas and how it may be influenced by changes in sulfur amino acid levels in disease states.

Since the enzymes in the transsulfuration pathway, CBS and CSE, catalyze elimination/addition reactions at the β- and γ-positions of sulfur-containing amino acids, respectively, they are logical candidates for the generation of H2S. However, conflicting reports in the literature ascribe the generation of H2Sby CBS and CSE to different substrates. For example, cystine was proposed to be the preferred substrate for H2S by CSE (23), whereas the β-replacement of cysteine by homocysteine is reported to be the preferred route for H2S generation by CBS (27). In this study, we have investigated the various reactions catalyzed by CSE that result in H2S biogenesis and, as side products, the novel amino acids, lanthionine and homolanthionine. The multitude of H2S-generating reactions (Scheme 1) and the relatively high Kms for homocysteine and cysteine exhibited by CSE versus the intracellular concentrations of these amino acids makes kinetic analysis complex and necessitates the use of simulations to deconvolute the contributions of different substrates to the overall H2S pool.

SCHEME 1.

SCHEME 1.

Postulated reaction mechanisms for CSE-catalyzed reactions with cysteine and homocysteine.

The reaction catalyzed by CSE in the transsulfuration pathway involves elimination at the γ-carbon of cystathionine. We find that the catalytic efficiency (kcat/Km) of the canonical cysteine elimination reaction from cystathionine is ∼20- and ∼30-fold higher than for H2S elimination from homocysteine and cysteine, respectively (Table 1). At physiologically relevant concentrations of homocysteine (10 μm), cysteine (100 μm), and cystathionine (5 μm), the turnover number for cystathionine cleavage (0.039 s-1) is still 5-fold greater than for cysteine cleavage (0.008 s-1) and ∼12-fold higher than for homocysteine cleavage (0.0034 s-1) (Table 2). Under these conditions, the α,β-elimination of cysteine catalyzed by CSE (Fig. 1, reaction 2) is the major source of H2S, accounting for ∼70% of its production, whereas the α,γ-elimination of homocysteine (reaction 4) accounts for ∼29% (Table 3 and Fig. 6).

The normal range for plasma total homocysteine concentration in humans is ∼6-15 μm and is ∼25-fold lower than the concentration of total cysteine (∼250 μm) (34). In patients with hyperhomocysteinemia, plasma homocysteine levels can range from 20-50 μm (in moderate hyperhomocysteinemia) to >100 μm (severe hyperhomocysteinemia) (35). Since CSE catalyzes homocysteine-dependent production of H2S, we have simulated the effect of moderate (40 μm) and severe (200 μm) hyperhomocysteinemic conditions, which boost the ratio of homocysteine/cysteine, on H2S biogenesis. As expected, H2S derived from homocysteine-dependent reactions increased proportionately with the grade of hyperhomocysteinemia (Table 3 and Fig. 6). The reaction displaying the greatest sensitivity to homocysteine concentrations was the condensation of 2 mol of homocysteine to give homolanthionine catalyzed by CSE (Fig. 1, reaction 5), which increased ∼230-fold at severely elevated homocysteine concentrations (Table 2). Under these conditions, homocysteine rather than cysteine becomes the preferred source for CSE-derived H2S.

The sensitivity of the CSE-catalyzed γ-replacement reaction to homocysteine suggests that homolanthionine, which is expected to be more stable than H2S, could be a suitable biomarker for this reaction. Indeed, homolanthionine was reported in urine samples from homocystinuric patients nearly 4 decades ago, when it was proposed to be derived from homocysteine or homoserine metabolism (36). The first report of biologically derived homolanthionine dates back to 1963 in a mutant strain of E. coli (37), and the accumulation of this compound was later reported in other organisms (38, 39). In Corynebacterium glutamicum, homolanthionine is an intermediate in a novel pathway for isoleucine synthesis (40). Homolanthionine formation by both rat and human liver CSE by the condensation of homocysteine and homoserine has been reported (41). Our study reveals that homolanthionine is generated by the condensation of two homocysteine molecules in a reaction catalyzed by CSE, thus linking the origin of homolanthionine to homocysteine metabolism and CSE. Homolanthionine could potentially be catabolized by reversal of the CSE reaction, and the metabolic fate of this compound needs to be evaluated.

Our results suggest that under hyperhomocysteinemic conditions, H2S production may be enhanced and could contribute to the associated cardiovascular pathology. In an in vivo model for myocardial ischemia-reperfusion, a U-shaped H2S dose dependence curve was observed, with the cardioprotective effect of H2S decreasing at higher concentrations (7). In a rat model of stroke, administration of high NaHS levels increased infarct volume (42), and H2S was found to be proinflammatory in a mouse endotoxic shock model (8). Mutations in CBS are the most common cause of severe hyperhomocysteinemia in comparison with defects elsewhere in the pathway (e.g. methionine synthase, methyltetrahydrofolate reductase, and methionine synthase reductase). In homocystinuric individuals with CBS deficiency, CSE may be the major source of H2S. Our studies suggest that inhibition of CSE in hyperhomocysteinemic individuals could be a useful strategy for attenuating the attendant cardiovascular pathology seen with this disease.

Lanthionine is another novel sulfur-containing amino acid that is a by-product of H2S production by CSE (Fig. 1, reaction 3). Although this thioether is a component of the class of peptide-containing antibiotics known as lantibiotics (43), its role, if any, in mammalian biology is not known. The presence of the cyclic lanthionine ketamine compound has been reported in bovine brain (44), where it has been shown to bind with high affinity (58 nm) to membranes, suggesting a possible role for this compound in the central nervous system (45). CBS can catalyze the synthesis of lanthionine from either cysteine or cysteine and serine (46). Our results demonstrate that CSE can also catalyze the synthesis of lanthionine from cysteine. The relative importance of CBS versus CSE in lanthionine production awaits further elucidation.

In conclusion, our study reveals the relative importance of cysteine-versus homocysteine-dependent reactions to H2S biogenesis catalyzed by CSE. Since these CSE-dependent routes for H2S generation represent side reactions relative to its role in the transsulfuration pathway, it is critically important to understand how these enzymatic reactions are regulated so that the same catalyst can serve dual roles. In some cell types, such as vascular endothelial cells, the transsulfuration pathway is not intact, since CBS is reported to be absent (47). Since H2Sisa signaling molecule, it is to be expected that its generation is regulated, and Ca2+-calmodulin has been reported to activate CSE (20). Under hyperhomocysteinemic conditions, H2S homeostasis may be dysregulated and could contribute to the cardiovascular etiology associated with this disease.

Supplementary Material

[Supplemental Data]
M808026200_index.html (1.3KB, html)

Acknowledgments

We thank Dr. Ashraf Raza and Ron Cerny (University of Nebraska, Lincoln) for help with the mass spectrometric data and Dr. Dave Ballou (University of Michigan) for helpful discussions on the kinetic simulations.

*

This work was supported, in whole or in part, by National Institutes of Health Grant HL58984 (to R. B.). This work was also supported by an American Heart Association postdoctoral fellowship award (to W. Z.).

The on-line version of this article (available at http://www.jbc.org) contains Tables S1-S3.

Footnotes

3

The abbreviations used are: PLP, pyridoxal 5′-phosphate; CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; DTNB, dithiobisnitrobenzene; HPLC, high pressure liquid chromatography; MS, mass spectrometry; HCys, homocysteine.

References

  • 1.Wang, R. (2002) FASEB J. 16 1792-1798 [DOI] [PubMed] [Google Scholar]
  • 2.Szabo, C. (2007) Nat. Rev. Drug Discov. 6 917-935 [DOI] [PubMed] [Google Scholar]
  • 3.Li, L., Bhatia, M., and Moore, P. K. (2006) Curr. Opin. Pharmacol. 6 125-129 [DOI] [PubMed] [Google Scholar]
  • 4.Goodwin, L. R., Francom, D., Dieken, F. P., Taylor, J. D., Warenycia, M. W., Reiffenstein, R. J., and Dowling, G. (1989) J. Anal. Toxicol. 13 105-109 [DOI] [PubMed] [Google Scholar]
  • 5.Abe, K., and Kimura, H. (1996) J. Neurosci. 16 1066-1071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhao, W., Zhang, J., Lu, Y., and Wang, R. (2001) EMBO J. 20 6008-6016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Elrod, J. W., Calvert, J. W., Morrison, J., Doeller, J. E., Kraus, D. W., Tao, L., Jiao, X., Scalia, R., Kiss, L., Szabo, C., Kimura, H., Chow, C. W., and Lefer, D. J. (2007) Proc. Natl. Acad. Sci. U. S. A. 104 15560-15565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Li, L., Bhatia, M., Zhu, Y. Z., Zhu, Y. C., Ramnath, R. D., Wang, Z. J., Anuar, F. B., Whiteman, M., Salto-Tellez, M., and Moore, P. K. (2005) FASEB J. 19 1196-1198 [DOI] [PubMed] [Google Scholar]
  • 9.Bhatia, M., Wong, F. L., Fu, D., Lau, H. Y., Moochhala, S. M., and Moore, P. K. (2005) FASEB J 19 623-625 [DOI] [PubMed] [Google Scholar]
  • 10.Trevisani, M., Patacchini, R., Nicoletti, P., Gatti, R., Gazzieri, D., Lissi, N., Zagli, G., Creminon, C., Geppetti, P., and Harrison, S. (2005) Br. J. Pharmacol. 145 1123-1131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fiorucci, S., Antonelli, E., Distrutti, E., Rizzo, G., Mencarelli, A., Orlandi, S., Zanardo, R., Renga, B., Di Sante, M., Morelli, A., Cirino, G., and Wallace, J. L. (2005) Gastroenterology 129 1210-1224 [DOI] [PubMed] [Google Scholar]
  • 12.Blackstone, E., Morrison, M., and Roth, M. B. (2005) Science 308 518. [DOI] [PubMed] [Google Scholar]
  • 13.Stipanuk, M. H., and Beck, P. W. (1982) Biochem. J. 206 267-277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kamoun, P. (2004) Amino Acids 26 243-254 [DOI] [PubMed] [Google Scholar]
  • 15.Ishii, I., Akahoshi, N., Yu, X. N., Kobayashi, Y., Namekata, K., Komaki, G., and Kimura, H. (2004) Biochem. J. 381 113-123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Eto, K., Ogasawara, M., Umemura, K., Nagai, Y., and Kimura, H. (2002) J. Neurosci. 22 3386-3391 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 17.Vitvitsky, V., Thomas, M., Ghorpade, A., Gendelman, H. E., and Banerjee, R. (2006) J. Biol. Chem. 281 35785-35793 [DOI] [PubMed] [Google Scholar]
  • 18.Diwakar, L., and Ravindranath, V. (2007) Neurochem. Int. 50 418-426 [DOI] [PubMed] [Google Scholar]
  • 19.Eto, K., Ogasawara, M., Umemura, K., Nagai, Y., and Kimura, H. (2004) J. Neurosci. 24 5649. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 20.Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A. K., Mu, W., Zhang, S., Snyder, S. H., and Wang, R. (2008) Science 322 587-590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aitken, S. M., and Kirsch, J. F. (2005) Arch. Biochem. Biophys. 433 166-175 [DOI] [PubMed] [Google Scholar]
  • 22.Szczepkowski, T. W., and Wood, J. L. (1967) Biochim. Biophys. Acta 139 469-478 [DOI] [PubMed] [Google Scholar]
  • 23.Cavallini, D., Mondovi, B., De Marco, C., and Sciosciasantoro, A. (1962) Arch. Biochem. Biophys. 96 456-457 [DOI] [PubMed] [Google Scholar]
  • 24.Zhu, W., Lin, A., and Banerjee, R. (2008) Biochemistry 47 6226-6232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Steegborn, C., Clausen, T., Sondermann, P., Jacob, U., Worbs, M., Marinkovic, S., Huber, R., and Wahl, M. C. (1999) J. Biol. Chem. 274 12675-12684 [DOI] [PubMed] [Google Scholar]
  • 26.Willhardt, I., and Wiederanders, B. (1975) Anal. Biochem. 63 263-266 [DOI] [PubMed] [Google Scholar]
  • 27.Chen, X., Jhee, K. H., and Kruger, W. D. (2004) J. Biol. Chem. 279 52082-52086 [DOI] [PubMed] [Google Scholar]
  • 28.Soda, K. (1968) Anal. Biochem. 25 228-235 [DOI] [PubMed] [Google Scholar]
  • 29.Tokoro, M., Asai, T., Kobayashi, S., Takeuchi, T., and Nozaki, T. (2003) J. Biol. Chem. 278 42717-42727 [DOI] [PubMed] [Google Scholar]
  • 30.Canevari, L., Vieira, R., Aldegunde, M., and Dagani, F. (1992) Anal. Biochem. 205 137-142 [DOI] [PubMed] [Google Scholar]
  • 31.Alvarez, M. P., Jimenez, V., Cano, P., Rebollar, P., Cardinali, D. P., and Esquifino, A. I. (2006) Gen. Comp. Endocrinol. 146 257-264 [DOI] [PubMed] [Google Scholar]
  • 32.Abeles, R. H., and Walsh, C. (1973) J. Am. Chem. Soc. 95 6124-6125 [DOI] [PubMed] [Google Scholar]
  • 33.Benavides, G. A., Squadrito, G. L., Mills, R. W., Patel, H. D., Isbell, T. S., Patel, R. P., Darley-Usmar, V. M., Doeller, J. E., and Kraus, D. W. (2007) Proc. Natl. Acad. Sci. U. S. A. 104 17977-17982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ueland, P. M. (1995) Clin. Chem. 41 340-342 [PubMed] [Google Scholar]
  • 35.Kang, S. S., Wong, P. W., and Malinow, M. R. (1992) Annu. Rev. Nutr. 12 279-298 [DOI] [PubMed] [Google Scholar]
  • 36.Perry, T. L., Hansen, S., and MacDougall, L. (1966) Science 152 1750-1752 [DOI] [PubMed] [Google Scholar]
  • 37.Huang, H. T. (1963) Biochemistry 2 296-298 [DOI] [PubMed] [Google Scholar]
  • 38.Neuberger, A., Sandy, J. D., and Tait, G. H. (1973) Biochem. J. 136 477-490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Paszewski, A., and Grabski, J. (1975) Acta Biochim. Pol. 22 263-268 [PubMed] [Google Scholar]
  • 40.Kromer, J. O., Heinzle, E., Schroder, H., and Wittmann, C. (2006) J. Bacteriol. 188 609-618 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tallan, H. H., Pascal, T. A., Schneidman, K., Gillam, B. M., and Gaull, G. E. (1971) Biochem. Biophys. Res. Commun. 43 303-310 [DOI] [PubMed] [Google Scholar]
  • 42.Qu, K., Chen, C. P., Halliwell, B., Moore, P. K., and Wong, P. T. (2006) Stroke 37 889-893 [DOI] [PubMed] [Google Scholar]
  • 43.Willey, J. M., and van der Donk, W. A. (2007) Annu. Rev. Microbiol. 61 477-501 [DOI] [PubMed] [Google Scholar]
  • 44.Ricci, G., Vesci, L., Nardini, M., Arduini, A., Storto, S., Rosato, N., and Cavallini, D. (1989) Biochim. Biophys. Acta 990 211-215 [DOI] [PubMed] [Google Scholar]
  • 45.Fontana, M., Ricci, G., Solinas, S. P., Antonucci, A., Serao, I., Dupre, S., and Cavallini, D. (1990) Biochem. Biophys. Res. Commun. 171 480-486 [DOI] [PubMed] [Google Scholar]
  • 46.Braunstein, A. E., and Goryachenkova, E. V. (1984) Adv. Enzymol. Relat. Areas Mol. Biol. 56 1-89 [DOI] [PubMed] [Google Scholar]
  • 47.Chen, P., Poddar, R., Tipa, E. V., Dibello, P. M., Moravec, C. D., Robinson, K., Green, R., Kruger, W. D., Garrow, T. A., and Jacobsen, D. W. (1999) Adv. Enzyme Regul. 39 93-109 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental Data]
M808026200_index.html (1.3KB, html)

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES